2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Lance – Adams Syndrome: a Case Series from Vietnam

HA. Nguyen, HK. Vo (Hanoi, Viet Nam)
Late-onset neurologic Wilson’s disease: case series

I. Minaev, E. Nuzhnyi, V. Poleschuk, A. Protopopova, N. Abramycheva, S. Illarioshkin (Moscow, Russian Federation)
Latent Genetic Architecture of Parkinson’s Disease Risk factors and Comorbidities

J. Kim, I. Foote, S. Bandres-Ciga, 23. Research Team, C. Marshall, A. Grotzinger3, A. Singleton, A. Brentnall, C. Blauwendraat, A. Noyce, G. Genetics Program (London, United Kingdom)
Leg Stereotypy Syndrome: Phenomenological and Quantitative Analysis

A. Yilmaz, E. Ruzicka, J. Jankovic (Houston, USA)
Legmain/Asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment

D. Taniguchi, T. Hatano, Y. Imai, N. Hattori (Tokyo, Japan)
Lessons from the COVID-19 Lockdown: A Novel Mentorship Program for Young Neurosurgeons, Neurologists and Medical Students

M. Elsayed, A. Motawei, A. Abdelrahman, A. Elgohary, B. Lashin, F. Monib, A. Abdelaal, E. Abdelazim, H. Basem (Mansoura, Egypt)
Levels of change in interleukin-6 levels according to clinical forms of Parkinson’s disease in patients with and without Covid-19

B. Muminov, R. Matmurodov (Tashkent, Uzbekistan)
Levels of change in interleukin-6 levels according to clinical stages of Parkinson’s disease in patients with and without Covid-19

R. Juraev, B. Muminov, R. Matmurodov (Tashkent, Uzbekistan)
Levels of ferritinemia in Parkinson’s disease patients who underwent Covid-19

B. Amonov, R. Matmurodov, B. Muminov (Tashkent, Uzbekistan)
Leveraging Large-Scale Proteomics to Identify Protein Quantitative Trait Loci and Causal Effects on Parkinson’s Disease

M. Lai, B. Benitez (Boston, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z